Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Surgical techniques.

T Lerut1, W Coosemans, G Decker

  • 1Department of Thoracic Surgery, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium. Toni.Lerut@uz.kuleuven.ac.be

Journal of Surgical Oncology
|November 22, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Breath- and blood-based molecular assessment for gastroesophageal cancer.

ESMO gastrointestinal oncology·2026
Same author

Proton versus photon therapy for esophageal cancer - A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2023
Same author

Major Intraoperative Complications During Minimally Invasive Esophagectomy.

Annals of surgical oncology·2023
Same author

Current practice in antireflux and hiatal hernia surgery: exploration of the Belgian field.

Acta chirurgica Belgica·2022
Same author

Prevalence of microsatellite instable and Epstein-Barr Virus-driven gastroesophageal cancer in a large Belgian cohort.

Acta gastro-enterologica Belgica·2022
Same author

Corrigendum to "Clinical Presentation, Natural History, and Therapeutic Approach in Patients with Solitary Fibrous Tumor: A Retrospective Analysis".

Sarcoma·2021
Same journal

Comparative Analysis of CEM and Breast MRI: A Retrospective Study.

Journal of surgical oncology·2026
Same journal

The Treatment Efficacy for Patients Undergoing Combined Transanal-Transabdominal Endoscopic Resection of Rectal Anastomosis Stenosis.

Journal of surgical oncology·2026
Same journal

"It Depends on the Situation": Variability in How Surgical Oncologists Elicit and Integrate Patient Values.

Journal of surgical oncology·2026
Same journal

A Tale of Two Pathways: Same-Surgeon Versus Different-Surgeon Resection After Second Surgical Opinion.

Journal of surgical oncology·2026
Same journal

How I Do It: The Life and Work of a Rubber Band in Robotic Liver Parenchymal Transection.

Journal of surgical oncology·2026
Same journal

New Paradigms of Cancer Require New Language: A Qualitative Study Exploring Language for Non-Curative Non-Palliative Cancer Surgery.

Journal of surgical oncology·2026
See all related articles

Esophageal and gastroesophageal junction adenocarcinoma often presents at advanced stages. Complete resection and lymph node status are key for survival, with 5-year survival over 40% for R0 resection.

Area of Science:

  • Gastroenterology
  • Surgical Oncology
  • Oncology

Background:

  • Esophageal and gastroesophageal junction adenocarcinoma incidence is rising.
  • Most patients are diagnosed with advanced disease, including transmural growth and lymph node metastasis.
  • Current staging methods, including CT, EUS, and PET, remain suboptimal for predicting lymph node dissemination.

Purpose of the Study:

  • To review current surgical techniques for esophageal and gastroesophageal junction adenocarcinoma.
  • To discuss prognostic factors and survival outcomes.
  • To establish benchmarks for therapeutic modalities.

Main Methods:

  • Review of surgical techniques for adenocarcinoma of the esophagus and gastroesophageal junction.
  • Analysis of prognostic determinants such as resection completeness and lymph node status.

Related Experiment Videos

  • Evaluation of survival data based on treatment outcomes.

    • Main Results:

    • Primary surgery for these cancers has low mortality (<5%) in high-volume centers.
    • Completeness of resection (R0) and lymph node status (N0/N1) are critical prognostic factors.
    • Five-year survival rates are over 40% for R0 resection and exceed 70% for node-negative (N0) patients.

    Conclusions:

    • Surgical management of esophageal and GEJ adenocarcinoma has improved, with low mortality.
    • R0 resection and achieving a node-negative status significantly improve patient survival.
    • Current surgical outcomes should serve as a benchmark for evaluating alternative therapies.